Times Square Capital Management, LLC Codex Dna, Inc. Transaction History

Times Square Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$1.8 - $6.45 $1.05 Million - $3.76 Million	-582,600 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$4.12 - $10.36 $92,288 - $232,064	-22,400 Reduced 3.7%	582,600 $3.13 Million
Q4 2021 Feb 04, 2022	SELL	$6.31 - $11.96 $29,026 - $55,016	-4,600 Reduced 0.75%	605,000 $6.53 Million
Q3 2021 Nov 08, 2021	SELL	$10.15 - $19.88 $376,565 - $737,548	-37,100 Reduced 5.74%	609,600 $6.79 Million
Q2 2021 Aug 09, 2021	BUY	$17.76 - $22.0 $11.5 Million - $14.2 Million	646,700 New	646,700 $14.2 Million

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.